Nanosciences and Nanosciences and nanotechnologies: nanotechnologies: European ActionEuropean Action

2005-20092005-2009

Eva HellstenEva HellstenEuropean CommissionEuropean Commission

DG EnvironmentDG Environment

Relation with EU Action Plan on Relation with EU Action Plan on Environment and HealthEnvironment and Health

Action 8 of E&H Action PlanAction 8 of E&H Action Plan

‘‘2004-2006: The Community will work with Member States and 2004-2006: The Community will work with Member States and international organisations, notably the WHO, to…address… international organisations, notably the WHO, to…address… possible environmental and human health impacts of nanoparticles’possible environmental and human health impacts of nanoparticles’

Policy is being developed under the Communication ‘Policy is being developed under the Communication ‘Nanosciences Nanosciences and nanotechnologies: an Action Plan for Europe 2005-2009’.and nanotechnologies: an Action Plan for Europe 2005-2009’.http://europa.eu.int/eur-lex/lex/LexUriServ/site/en/com/2005/com2005_0243en01.pdfhttp://europa.eu.int/eur-lex/lex/LexUriServ/site/en/com/2005/com2005_0243en01.pdf

This presentation focuses on the work plan outlined in this This presentation focuses on the work plan outlined in this Nanotechnology Action Plan, and the state of play on Nanotechnology Action Plan, and the state of play on implementation. References to the ‘Action Plan’ from now on are to implementation. References to the ‘Action Plan’ from now on are to the Nanotech Action Plan.the Nanotech Action Plan.

Setting the scene….Setting the scene….

Breakthrough in science - ability to control matter at the Breakthrough in science - ability to control matter at the atomic levelatomic level

Widespread industrial applications for materials and Widespread industrial applications for materials and devices with new properties due to the small sizedevices with new properties due to the small size

Developed and introduced into the market with high Developed and introduced into the market with high speed all over the world.speed all over the world.

Huge benefits, but uncertainties about health, safety and Huge benefits, but uncertainties about health, safety and environment aspects….environment aspects….

Huge potential benefits…….Huge potential benefits…….

Economic development, boost for R&D and Economic development, boost for R&D and industrial innovation – Lisbon agenda industrial innovation – Lisbon agenda

Technical innovations to increase social welfare Technical innovations to increase social welfare – medicinal applications, electronics, durable – medicinal applications, electronics, durable materials etc.materials etc.

Sustainable development through less energy Sustainable development through less energy and material input, and environment remediationand material input, and environment remediation

……..but also concern about ..but also concern about potential impactspotential impacts…………

Free nanoparticles potentially harmful to health Free nanoparticles potentially harmful to health and environment (reactivity, penetration into and environment (reactivity, penetration into body, brain and cells, PBT properties?)body, brain and cells, PBT properties?)

Unknown exposures (workplaces, consumers, Unknown exposures (workplaces, consumers, via environment or food-chain?)via environment or food-chain?)

Long term concerns for non-ethical applicationsLong term concerns for non-ethical applications

The European Approach….The European Approach…. …. …. aa safe, integrated and responsible safe, integrated and responsible strategy for N&Nstrategy for N&N….….

Towards a European Strategy for Towards a European Strategy for Nanotechnology adopted in May 2004 Nanotechnology adopted in May 2004

Implementing activities proposed in Implementing activities proposed in the the Action PlanAction Plan for Europe 2005-2009for Europe 2005-2009 adopted in June 2005adopted in June 2005

Nanotechnology in a broader Nanotechnology in a broader policy contextpolicy context

Researchand

Development

Societal Issues

Infrastructure

HumanResources

IndustrialInnovation

Lisbon agenda

Sustainable Development

Health, safety, environmental and

consumer protection

International collaboration

Eight groups of actions divided intoEight groups of actions divided into

1.1. Research, Development and InnovationResearch, Development and Innovation

2.2. Infrastructure and European Poles of ExcellenceInfrastructure and European Poles of Excellence

3.3. Interdisciplinary Human Resources: Europe needs CreativityInterdisciplinary Human Resources: Europe needs Creativity

4.4. Industrial Innovation: From Knowledge to the MarketIndustrial Innovation: From Knowledge to the Market

5.5. Integrating the Societal Dimension: Expectations and Integrating the Societal Dimension: Expectations and ConcernsConcerns

6.6. Public Health, Safety, Environment and Consumer ProtectionPublic Health, Safety, Environment and Consumer Protection

7.7. International CooperationInternational Cooperation

8.8. Implementing a Coherent Approach at European LevelImplementing a Coherent Approach at European Level

What has COM done so far?What has COM done so far?

R&D investments under 4-6R&D investments under 4-6thth FP – FP – supporting innovation, education, centres supporting innovation, education, centres of excellence, SMEs; including health and of excellence, SMEs; including health and safety aspectssafety aspects

Addressing environment and health Addressing environment and health concerns (chapter 6)concerns (chapter 6)

Promoting and participating in international Promoting and participating in international collaborationcollaboration

R&D investments under the R&D investments under the Framework ProgrammesFramework Programmes

FP4 1994-1998 FP4 1994-1998 120 M€ 120 M€

FP5 1998-2002 FP5 1998-2002 280 M€ 280 M€

FP6 2002-2006 FP6 2002-2006 13001300 M€ M€

2005~460 € millionestimated

NMP, 209.01

IST, 175.11

Marie Curie, 39.73

NEST, 8.15

Infrastructure, 16.46ERA-NET, 2.20

SMEs, 8.14Science and Society, 1.09

Growth of Support for Nanotech at Growth of Support for Nanotech at EU LevelEU Level

0

50

100

150

200

250

300

350

400

450

500

1997 1998 1999 2000 2001 2002 2003 2004 2005

Pu

bli

c F

un

din

g (

€)

FP4

FP5

FP6

Source: European Commission (2005)

R&

D e

xpen

dit

ure

( M

€)R

&D

exp

end

itu

re (

M€)

Areas Supported by the FPsAreas Supported by the FPs

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

FP4 FP5 FP6

Health / Environment

Research Training

Nanotools

Nanoelectronics

Nanobio / Nanomedicine

Nanomaterials

Frontier Research

As comparison - R&D expenditures As comparison - R&D expenditures world-wide 2004world-wide 2004

R&

D e

xpen

dit

ure

( M

€ )

R&

D e

xpen

dit

ure

( M

€ )

Source: European Commission (2005)

Public540

Public750

Federal910

EC370

States333

MemberStates +

Associated980

Private370

Private1540

Private1700

Private580

0

1,000

2,000

3,000

Europe US Japan Others

Pu

bli

c R

&D

In

vest

men

t (€

)

Action Plan on Environment and Action Plan on Environment and Health Safety issues Chapter 6Health Safety issues Chapter 6

Improve Improve knowledge baseknowledge base - definitions, - definitions, measurements, toxicological and measurements, toxicological and ecotoxicological test methods, exposures, ecotoxicological test methods, exposures, risk assessmentrisk assessment

Regulatory aspectsRegulatory aspects – inventory of existing – inventory of existing legislationlegislation

Expected Opinion from the Expected Opinion from the Scientific Committee Scientific Committee

(SCENIHR) in October 2005(SCENIHR) in October 2005on assessment of on assessment of

risks and methodologiesrisks and methodologies

Environment and Health - filling Environment and Health - filling knowledge gapsknowledge gaps

Workshops:Workshops: A Preliminary Risk Analysis A Preliminary Risk Analysis

(March 2004)(March 2004) Research Needs for Research Needs for

Nanoparticles (Jan 2005)Nanoparticles (Jan 2005)

E&H in Research ProgrammesE&H in Research Programmes

NANOSAFENANOSAFE NANODERMNANODERM NANOPATHOLOGYNANOPATHOLOGY MAAPHRIMAAPHRI NANOFORUMNANOFORUM NANOTOXNANOTOX IMPARTIMPART NANOSAFE2NANOSAFE2

7th Framework Programme 7th Framework Programme

Technological Platforms Technological Platforms

>8M€

~2.5M€

New structures form completely new classes of materials

That will be used in many industrial sectors – lifecycle perspective

Material processing

Manufacture Use RecoveryDistribution

ReuseRecycle

WasteRaw material

Inventory of current legislationInventory of current legislation

Chemicals legislation:Chemicals legislation: NewNew andand existingexisting substances substances legislationlegislation to generate data, safety measures, like to generate data, safety measures, like classification and labelling, and risk management. Will classification and labelling, and risk management. Will likely be replaced by REACH and GHS.likely be replaced by REACH and GHS.

Pharmaceuticals, Pesticides, BiocidesPharmaceuticals, Pesticides, Biocides – authorisation – authorisation schemesschemes

Medical devices, cosmetics, food additives and Medical devices, cosmetics, food additives and packages packages

Worker protectionWorker protection

Air, Water, IPPC, Seveso, Waste, Environment Air, Water, IPPC, Seveso, Waste, Environment Liability, Product liability, Product safetyLiability, Product liability, Product safety

Identifying knowledge gaps from Identifying knowledge gaps from an E&H perspectivean E&H perspective

nomenclature, definitions, nomenclature, definitions, hazard characterisation;hazard characterisation; exposure and effects assessment; exposure and effects assessment; fate, transport, persistence etc. in fate, transport, persistence etc. in

environmental media;environmental media; measurement, sampling and monitoring;measurement, sampling and monitoring;

Some events in 2005Some events in 2005

FebrFebr UK Government: National AgendaUK Government: National AgendaJuneJune OECD Chemicals Committee: Special Session on OECD Chemicals Committee: Special Session on

potential implications of nanomaterials. potential implications of nanomaterials. JuneJune EU Commission: An Action Plan for EU 2005-09EU Commission: An Action Plan for EU 2005-09JuneJune US EPA: Proposal for a voluntary notification US EPA: Proposal for a voluntary notification

scheme under the chemicals legislation (TCSA)scheme under the chemicals legislation (TCSA)JulyJuly International dialogue in Brussels on collaboration International dialogue in Brussels on collaboration

in in R&D (25 countries)R&D (25 countries)OctOct Germany: Stakeholders conference in BonnGermany: Stakeholders conference in BonnOctOct UK presidency workshopUK presidency workshopDecDec 22ndnd OECD workshop in Washington OECD workshop in Washington

Challenges for policy makersChallenges for policy makers

To strike the right balance between To strike the right balance between

Creating a good climate and conditions for Creating a good climate and conditions for innovation and development of applications, innovation and development of applications, contributing to economic growth, welfare and contributing to economic growth, welfare and sustainable developmentsustainable development

Ensuring that potential risks to environment and Ensuring that potential risks to environment and human health, as well as public and ethical human health, as well as public and ethical concerns, are looked into and dealt with at an concerns, are looked into and dealt with at an early stageearly stage